Provided by Tiger Trade Technology Pte. Ltd.

Novavax

8.28
+0.30003.76%
Volume:1.15M
Turnover:9.57M
Market Cap:1.35B
PE:3.21
High:8.60
Open:8.57
Low:8.24
Close:7.98
52wk High:11.97
52wk Low:5.01
Shares:162.50M
Float Shares:136.72M
Volume Ratio:1.33
T/O Rate:0.84%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.58
EPS(LYR):2.58
ROE:-898.20%
ROA:25.72%
PB:-10.53
PE(LYR):3.21

Loading ...

Stock Track | Novavax Soars 5.06% Despite Price Target Cut as B. Riley Maintains Buy Rating

Stock Track
·
Nov 12, 2025

Novavax price target lowered to $16 from $18 at B. Riley

TIPRANKS
·
Nov 11, 2025

Novavax Inc. Stock Slides 4.4%, Underperforms Peers

Dow Jones
·
Nov 11, 2025

B. Riley Adjusts Price Target on Novavax to $16 From $18, Maintains Buy Rating

MT Newswires Live
·
Nov 10, 2025

Novavax Inc : B. Riley Cuts Target Price to $16 From $18

THOMSON REUTERS
·
Nov 10, 2025

Assessing Novavax (NVAX) Valuation Following Q3 Revenue Beat and Expanded Sanofi Collaboration

Simply Wall St.
·
Nov 10, 2025

Novavax Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
Nov 08, 2025

Novavax delays profitability target with eyes on Sanofi-led launches

Reuters
·
Nov 07, 2025

Novavax Exec Says Co Expects 2026 Adjusted Total Revenue Between $185 Million and $205 Million

THOMSON REUTERS
·
Nov 06, 2025

Novavax Exec Says Co Expects 2026-27 Season Nuvaxovid Royalties Will Grow Significantly as Compared to 2025 - Conf Call

THOMSON REUTERS
·
Nov 06, 2025

Earnings Flash (NVAX) Novavax Posts Q3 Net Loss $1.25 a Share, vs. FactSet Est of $1.20 Loss

MT Newswires Live
·
Nov 06, 2025

Stock Track | Novavax Soars 5.85% Pre-market on Better-than-Expected Q3 Results and Strong Revenue Outlook

Stock Track
·
Nov 06, 2025

Novavax Reports $70 Million Q3 Revenue and Raises 2025 Revenue Framework

Reuters
·
Nov 06, 2025

CORRECTED-UPDATE 3-Novavax defers profitability target by a year on weak COVID vaccine sales

Reuters
·
Nov 06, 2025

Novavax Outlook FY Adjusted Total Revenue USD 1,040-1,060 Million

THOMSON REUTERS
·
Nov 06, 2025

Novavax Outlook FY Adj Total Revenue $1.04 Bln-$1.06 Bln VS Ibes Estimate $1.05 Bln

THOMSON REUTERS
·
Nov 06, 2025

Novavax: Non-Cash Charges for Q3 Were $126 Mln

THOMSON REUTERS
·
Nov 06, 2025

Novavax beats quarterly revenue estimates on milestone payment

Reuters
·
Nov 06, 2025

Novavax Q3 EPS $(1.25) Beats $(1.33) Estimate, Sales $70.445M Beat $42.133M Estimate

Benzinga
·
Nov 06, 2025

Novavax Q3 Revenue $70.4 Mln VS Ibes Estimate $42.1 Mln

THOMSON REUTERS
·
Nov 06, 2025